The Application of Nanoparticles for Neuroprotection in Acute Ischemic Stroke

References

• Kim AS Cahill E Cheng NT . Global stroke belt: geographic variation in stroke burden worldwide. Stroke46 (12), 3564–3570 (2015).
   PubMed Web of Science ®Google Scholar
• Mozaffarian D Benjamin EJ Go AS et al. Heart disease and stroke statistics–2016 update: a report from the American Heart Association. Circulation133 (4), e38–e360 (2016).
   PubMed Web of Science ®Google Scholar
• Zheng S Bai YY Liu Y et al. Salvaging brain ischemia by increasing neuroprotectant uptake via nanoagonist mediated blood brain barrier permeability enhancement. Biomaterials66, 9–20 (2015).
   PubMed Web of Science ®Google Scholar
• Fan J Kamphorst JJ Mathew R et al. Glutamine-driven oxidative phosphorylation is a major ATP source in transformed mammalian cells in both normoxia and hypoxia. Mol. Syst. Biol.9, 712 (2013).
   PubMed Web of Science ®Google Scholar
• Lo EH Dalkara T Moskowitz MA . Mechanisms, challenges and opportunities in stroke. Nat. Rev. Neurosci.4 (5), 399–415 (2003).
   PubMed Web of Science ®Google Scholar
• Turner RC Dodson SC Rosen CL Huber JD . The science of cerebral ischemia and the quest for neuroprotection: navigating past failure to future success. J. Neurosurg.118 (5), 1072–1085 (2013).
   PubMed Web of Science ®Google Scholar
• Pundik S Xu K Sundararajan S . Reperfusion brain injury: focus on cellular bioenergetics. Neurology79 (13 Suppl. 1), S44–S51 (2012).
   PubMed Web of Science ®Google Scholar
• Rodrigo R Fernandez-Gajardo R Gutierrez R et al. Oxidative stress and pathophysiology of ischemic stroke: novel therapeutic opportunities. CNS Neurol. Disord Drug Targets12 (5), 698–714 (2013).
   PubMed Web of Science ®Google Scholar
• Thompson BJ Ronaldson PT . Drug delivery to the ischemic brain. Adv. Pharmacol.71, 165–202 (2014).
   PubMedGoogle Scholar
• Lopez-Neblina F Toledo AH Toledo-Pereyra LH . Molecular biology of apoptosis in ischemia and reperfusion. J. Invest. Surg.18 (6), 335–350 (2005).
   PubMed Web of Science ®Google Scholar
• Gross O Thomas CJ Guarda G Tschopp J . The inflammasome: an integrated view. Immunol. Rev.243 (1), 136–151 (2011).
   PubMed Web of Science ®Google Scholar
• Kong Y Le Y . Toll-like receptors in inflammation of the central nervous system. Int. Immunopharmacol.11 (10), 1407–1414 (2011).
   PubMed Web of Science ®Google Scholar
• Xiong XY Liu L Yang QW . Functions and mechanisms of microglia/macrophages in neuroinflammation and neurogenesis after stroke. Prog. Neurobiol.142, 23–44 (2016).
   PubMed Web of Science ®Google Scholar
• Vidale S Consoli A Arnaboldi M Consoli D . Postischemic inflammation in acute stroke. J. Clin. Neurol.13 (1), 1 (2017).
   PubMed Web of Science ®Google Scholar
• Kim JY Park J Chang JY Kim SH Lee JE . Inflammation after ischemic stroke: the role of leukocytes and glial cells. Exp. Neurobiol.25 (5), 241–251 (2016).
   PubMed Web of Science ®Google Scholar
• Anrather J Iadecola C . Inflammation and stroke: an overview. Neurotherapeutics13 (4), 661–670 (2016).
   PubMed Web of Science ®Google Scholar
• Fumagalli S Perego C Pischiutta F Zanier ER De Simoni MG . The ischemic environment drives microglia and macrophage function. Front. Neurol.6, 81 (2015).
   PubMed Web of Science ®Google Scholar
• Abbracchio MP Burnstock G Verkhratsky A Zimmermann H . Purinergic signalling in the nervous system: an overview. Trends Neurosci.32 (1), 19–29 (2009).
   PubMed Web of Science ®Google Scholar
• Ronaldson PT Davis TP . Blood–brain barrier integrity and glial support: mechanisms that can be targeted for novel therapeutic approaches in stroke. Curr. Pharm. Des.18 (25), 3624–3644 (2012).
   PubMed Web of Science ®Google Scholar
• Nair MG Guild KJ Artis D . Novel effector molecules in type 2 inflammation: lessons drawn from helminth infection and allergy. J. Immunol.177 (3), 1393–1399 (2006).
   PubMed Web of Science ®Google Scholar
• Baker WL Marrs JC Davis LE et al. Key articles and guidelines in the primary prevention of ischemic stroke. Pharmacotherapy33 (6), e101–e114 (2013).
   PubMed Web of Science ®Google Scholar
• Del ZG Saver JL Jauch EC Adams HJ . Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart Association/American Stroke Association. Stroke40 (8), 2945–2948 (2009).
   PubMed Web of Science ®Google Scholar
• Schwamm LH Ali SF Reeves MJ et al. Temporal trends in patient characteristics and treatment with intravenous thrombolysis among acute ischemic stroke patients at Get With The Guidelines-Stroke hospitals. Circ. Cardiovasc. Qual. Outcomes6 (5), 543–549 (2013).
   PubMed Web of Science ®Google Scholar
• Leiva-Salinas C Patrie JT Xin W et al. Prediction of early arterial recanalization and tissue fate in the selection of patients with the greatest potential to benefit from intravenous tissue-type plasminogen activator. Stroke47 (2), 397–403 (2016).
   PubMed Web of Science ®Google Scholar
• Khandelwal P Yavagal DR Sacco RL . Acute ischemic stroke intervention. J. Am. Coll. Cardiol.67 (22), 2631–2644 (2016).
   PubMed Web of Science ®Google Scholar
• Catanese L Tarsia J Fisher M . Acute ischemic stroke therapy overview. Circ. Res.120 (3), 541–558 (2017).
   PubMed Web of Science ®Google Scholar
• Bonaventura A Montecucco F Dallegri F . Update on the effects of treatment with recombinant tissue-type plasminogen activator (rt-PA) in acute ischemic stroke. Expert Opin. Biol. Ther.16 (11), 1323–1340 (2016).
   PubMed Web of Science ®Google Scholar
• Friedrich B Gawlitza M Fahnert J et al. Interventional ischemic stroke treatment–a (R)evolution. Rofo188 (3), 259–267 (2016).
   PubMedGoogle Scholar
• Powers WJ Derdeyn CP Biller J et al. 2015 American Heart Association/American Stroke Association focused update of the 2013 guidelines for the early management of patients with acute ischemic stroke regarding endovascular treatment: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke46 (10), 3020–3035 (2015).
   PubMed Web of Science ®Google Scholar
• Chamorro A Dirnagl U Urra X Planas AM . Neuroprotection in acute stroke: targeting excitotoxicity, oxidative and nitrosative stress, and inflammation. Lancet Neurol.15 (8), 869–881 (2016).
   PubMed Web of Science ®Google Scholar
• George PM Steinberg GK . Novel stroke therapeutics: unraveling stroke pathophysiology and its impact on clinical treatments. Neuron87 (2), 297–309 (2015).
   PubMed Web of Science ®Google Scholar
• O'Collins VE Macleod MR Donnan GA et al. 1,026 experimental treatments in acute stroke. Ann. Neurol.59 (3), 467–477 (2006).
   PubMed Web of Science ®Google Scholar
• Savitz SI Fisher M . Future of neuroprotection for acute stroke: in the aftermath of the SAINT trials. Ann. Neurol.61 (5), 396–402 (2007).
   PubMed Web of Science ®Google Scholar
• Feng W Belagaje SR . Recent advances in stroke recovery and rehabilitation. Semin. Neurol.33 (5), 498–506 (2013).
   PubMed Web of Science ®Google Scholar
• Boltze J Reich DM Hau S et al. Assessment of neuroprotective effects of human umbilical cord blood mononuclear cell subpopulations in vitro and in vivo. Cell Transplant.21 (4), 723–737 (2012).
   PubMed Web of Science ®Google Scholar
• Boltze J Schmidt UR Reich DM et al. Determination of the therapeutic time window for human umbilical cord blood mononuclear cell transplantation following experimental stroke in rats. Cell Transplant.21 (6), 1199–1211 (2012).
   PubMed Web of Science ®Google Scholar
• Boltze J Arnold A Walczak P et al. The dark side of the force–constraints and complications of cell therapies for stroke. Front. Neurol.6, 155 (2015).
   PubMed Web of Science ®Google Scholar
• Villeda SA Plambeck KE Middeldorp J et al. Young blood reverses age-related impairments in cognitive function and synaptic plasticity in mice. Nat. Med.20 (6), 659–663 (2014).
   PubMed Web of Science ®Google Scholar
• Gaudin A Yemisci M Eroglu H et al. Squalenoyl adenosine nanoparticles provide neuroprotection after stroke and spinal cord injury. Nat. Nanotechnol.9 (12), 1054–1062 (2014).
   PubMed Web of Science ®Google Scholar
• Elzoghby AO Abd-Elwakil MM Abd-Elsalam K et al. Natural polymeric nanoparticles for brain-targeting: implications on drug and gene delivery. Curr. Pharm. Des.22 (22), 3305–3323 (2016).
   PubMed Web of Science ®Google Scholar
• Patel T Zhou J Piepmeier JM Saltzman WM . Polymeric nanoparticles for drug delivery to the central nervous system. Adv. Drug Deliv. Rev.64 (7), 701–705 (2012).
   PubMed Web of Science ®Google Scholar
• Liu X An C Jin P Liu X Wang L . Protective effects of cationic bovine serum albumin-conjugated PEGylated tanshinone IIA nanoparticles on cerebral ischemia. Biomaterials34 (3), 817–830 (2013).
   PubMed Web of Science ®Google Scholar
• Chen C Mei H Shi W et al. EGFP-EGF1-conjugated PLGA nanoparticles for targeted delivery of siRNA into injured brain microvascular endothelial cells for efficient RNA interference. PLoS ONE8 (4), e60860 (2013).
   PubMed Web of Science ®Google Scholar
• Mdzinarishvili A Sutariya V Talasila PK Geldenhuys WJ Sadana P . Engineering triiodothyronine (T3) nanoparticle for use in ischemic brain stroke. Drug Deliv. Transl. Res.3 (4), 309–317 (2013).
   PubMed Web of Science ®Google Scholar
• Wang Y Cooke MJ Sachewsky N Morshead CM Shoichet MS . Bioengineered sequential growth factor delivery stimulates brain tissue regeneration after stroke. J. Control. Rel.172 (1), 1–11 (2013).
   PubMed Web of Science ®Google Scholar
• Nih LR Carmichael ST Segura T . Hydrogels for brain repair after stroke: an emerging treatment option. Curr. Opin. Biotechnol.40, 155–163 (2016).
   PubMed Web of Science ®Google Scholar
• Ferreira R Fonseca MC Santos T et al. Retinoic acid-loaded polymeric nanoparticles enhance vascular regulation of neural stem cell survival and differentiation after ischaemia. Nanoscale8 (15), 8126–8137 (2016).
   PubMed Web of Science ®Google Scholar
• Yemisci M Caban S Gursoy-Ozdemir Y et al. Systemically administered brain-targeted nanoparticles transport peptides across the blood-brain barrier and provide neuroprotection. J. Cereb. Blood Flow Metab.35 (3), 469–475 (2015).
   PubMed Web of Science ®Google Scholar
• Ding Y Qiao Y Wang M et al. Enhanced neuroprotection of acetyl-11-keto-beta-boswellic acid (AKBA)-loaded O-carboxymethyl chitosan nanoparticles through antioxidant and anti-inflammatory pathways. Mol. Neurobiol.53 (6), 3842–3853 (2016).
   PubMed Web of Science ®Google Scholar
• Joachim E Kim ID Jin Y et al. Gelatin nanoparticles enhance the neuroprotective effects of intranasally administered osteopontin in rat ischemic stroke model. Drug Deliv. Transl. Res.4 (5–6), 395–399 (2014).
   PubMed Web of Science ®Google Scholar
• Xing C Levchenko T Guo S et al. Delivering minocycline into brain endothelial cells with liposome-based technology. J. Cereb. Blood Flow Metab.32 (6), 983–988 (2012).
   PubMed Web of Science ®Google Scholar
• Peng T Britton GL Kim H et al. Therapeutic time window and dose dependence of xenon delivered via echogenic liposomes for neuroprotection in stroke. CNS Neurosci. Ther.19 (10), 773–784 (2013).
   PubMed Web of Science ®Google Scholar
• Fukuta T Ishii T Asai T et al. Treatment of stroke with liposomal neuroprotective agents under cerebral ischemia conditions. Eur. J. Pharm. Biopharm.97 (Pt A), 1–7 (2015).
   PubMedGoogle Scholar
• Lu YM Huang JY Wang H et al. Targeted therapy of brain ischaemia using Fas ligand antibody conjugated PEG-lipid nanoparticles. Biomaterials35 (1), 530–537 (2014).
   PubMed Web of Science ®Google Scholar
• Zhao Y Jiang Y Lv W et al. Dual targeted nanocarrier for brain ischemic stroke treatment. J. Control. Release233, 64–71 (2016).
   PubMed Web of Science ®Google Scholar
• Zhao H Bao XJ Wang RZ et al. Postacute ischemia vascular endothelial growth factor transfer by transferrin-targeted liposomes attenuates ischemic brain injury after experimental stroke in rats. Hum. Gene Ther.22 (2), 207–215 (2011).
   PubMed Web of Science ®Google Scholar
• Gao H Pang Z Jiang X . Targeted delivery of nano-therapeutics for major disorders of the central nervous system. Pharm. Res.30 (10), 2485–2498 (2013).
   PubMed Web of Science ®Google Scholar
• Kawaguchi AT Fukumoto D Haida M et al. Liposome-encapsulated hemoglobin reduces the size of cerebral infarction in the rat: evaluation with photochemically induced thrombosis of the middle cerebral artery. Stroke38 (5), 1626–1632 (2007).
   PubMed Web of Science ®Google Scholar
• Shimbo D Abumiya T Shichinohe H et al. Post-ischemic intra-arterial infusion of liposome-encapsulated hemoglobin can reduce ischemia reperfusion injury. Brain Res.1554, 59–66 (2014).
   PubMed Web of Science ®Google Scholar
• Takamiya M Miyamoto Y Yamashita T et al. Strong neuroprotection with a novel platinum nanoparticle against ischemic stroke- and tissue plasminogen activator-related brain damages in mice. Neuroscience221, 47–55 (2012).
   PubMed Web of Science ®Google Scholar
• Estevez AY Pritchard S Harper K et al. Neuroprotective mechanisms of cerium oxide nanoparticles in a mouse hippocampal brain slice model of ischemia. Free Radic Biol. Med.51 (6), 1155–1163 (2011).
   PubMed Web of Science ®Google Scholar
• Liu X Ye M An C Pan L Ji L . The effect of cationic albumin-conjugated PEGylated tanshinone IIA nanoparticles on neuronal signal pathways and neuroprotection in cerebral ischemia. Biomaterials34 (28), 6893–6905 (2013).
   PubMed Web of Science ®Google Scholar
• Mouhieddine TH Itani MM Nokkari A et al. Nanotheragnostic applications for ischemic and hemorrhagic strokes: improved delivery for a better prognosis. Curr. Neurol. Neurosci. Rep.15 (1), 505 (2015).
   PubMed Web of Science ®Google Scholar
• Kamaly N Yameen B Wu J Farokhzad OC . Degradable controlled-release polymers and polymeric nanoparticles: mechanisms of controlling drug release. Chem. Rev.116 (4), 2602–2663 (2016).
   PubMed Web of Science ®Google Scholar
• Maurer N Fenske DB Cullis PR . Developments in liposomal drug delivery systems. Expert Opin. Biol. Ther.1 (6), 923–947 (2001).
   PubMed Web of Science ®Google Scholar
• Shi J Kantoff PW Wooster R Farokhzad OC . Cancer nanomedicine: progress, challenges and opportunities. Nat. Rev. Cancer17 (1), 20–37 (2017).
   PubMed Web of Science ®Google Scholar
• Gilmore JL Yi X Quan L Kabanov AV . Novel nanomaterials for clinical neuroscience. J. Neuroimmune. Pharmacol3 (2), 83–94 (2008).
   PubMed Web of Science ®Google Scholar
• Dinda SC Pattnaik G . Nanobiotechnology-based drug delivery in brain targeting. Curr. Pharm. Biotechnol14 (15), 1264–1274 (2013).
   PubMed Web of Science ®Google Scholar
• Ramos-Cabrer P Agulla J Argibay B Perez-Mato M Castillo J . Serial MRI study of the enhanced therapeutic effects of liposome-encapsulated citicoline in cerebral ischemia. Int. J. Pharm.405 (1–2), 228–233 (2011).
   PubMedGoogle Scholar
• Zhou L Li F Xu HB et al. Treatment of cerebral ischemia by disrupting ischemia-induced interaction of nNOS with PSD-95. Nat. Med.16 (12), 1439–1443 (2010).
   PubMed Web of Science ®Google Scholar
• Nair SB Dileep A Rajanikant GK . Nanotechnology based diagnostic and therapeutic strategies for neuroscience with special emphasis on ischemic stroke. Curr. Med. Chem.19 (5), 744–756 (2012).
   PubMed Web of Science ®Google Scholar
• Hwang H Jeong HS Oh PS et al. Improving cerebral blood flow through liposomal delivery of angiogenic peptides: potential of 18F-FDG PET imaging in ischemic stroke treatment. J. Nucl. Med.56 (7), 1106–1111 (2015).
   PubMed Web of Science ®Google Scholar
• Li SD Huang L . Pharmacokinetics and biodistribution of nanoparticles. Mol. Pharm.5 (4), 496–504 (2008).
   PubMed Web of Science ®Google Scholar
• Das M Patil S Bhargava N et al. Auto-catalytic ceria nanoparticles offer neuroprotection to adult rat spinal cord neurons. Biomaterials28 (10), 1918–1925 (2007).
   PubMed Web of Science ®Google Scholar
• Schubert D Dargusch R Raitano J Chan SW . Cerium and yttrium oxide nanoparticles are neuroprotective. Biochem. Biophys. Res. Commun.342 (1), 86–91 (2006).
   PubMed Web of Science ®Google Scholar
• Boison D . Adenosine as a neuromodulator in neurological diseases. Curr. Opin. Pharmacol.8 (1), 2–7 (2008).
   PubMed Web of Science ®Google Scholar
• Williams-Karnesky RL Stenzel-Poore MP . Adenosine and stroke: maximizing the therapeutic potential of adenosine as a prophylactic and acute neuroprotectant. Curr. Neuropharmacol.7 (3), 217–227 (2009).
   PubMed Web of Science ®Google Scholar
• Fredholm BB Chen JF Cunha RA Svenningsson P Vaugeois JM . Adenosine and brain function. Int. Rev. Neurobiol.63, 191–270 (2005).
   PubMed Web of Science ®Google Scholar
• Panagiotou S Saha S . Therapeutic benefits of nanoparticles in stroke. Front. Neurosci.9, 182 (2015).
   PubMed Web of Science ®Google Scholar
• Pandey A Malek V Prabhakar V Kulkarni YA Gaikwad AB . Nanoparticles: a neurotoxicological perspective. CNS Neurol. Disord. Drug Targets14 (10), 1317–1327 (2015).
   PubMed Web of Science ®Google Scholar
• Pan CH Liu WT Bien MY et al. Effects of size and surface of zinc oxide and aluminum-doped zinc oxide nanoparticles on cell viability inferred by proteomic analyses. Int. J. Nanomedicine9, 3631–3643 (2014).
   PubMed Web of Science ®Google Scholar